Viewing nowCombinationAmlotelmi Tablet 40/5 Milligrams
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201607340 · Approved 2016.12.28 · Insurance code 656004410
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who do not achieve sufficient blood pressure control even when taking telmisartan or amlodipine alone. In other words, it helps manage blood pressure effectively in cases where existing treatments are insufficient.
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, switching to this drug (a combination product containing the same amounts of each active ingredient) may be considered for convenience (limited to this drug 40/5 mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: Although the usual amlodipine dosage is recommended for elderly patients, caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In patients 75 years of age and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
◦ Children: Administration of this drug is not recommended because its safety and efficacy have not been established in pediatric patients 18 years of age or younger.
This medication may pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by women who are pregnant or may become pregnant. Administration is contraindicated for patients with allergies to the active ingredient or related components, or with certain diseases such as liver, heart, or kidney conditions. Particularly, caution should be exercised in patients with impaired liver function, severe hypotension, or unstable cardiac function. While taking this medication, symptoms such as dizziness, edema, and hypotension may occur; if symptoms are severe, immediate consultation with a healthcare professional is advised. Because of its strong blood pressure-lowering effect, careful attention is needed for patients with insufficient fluid or salt, as hypotension may occur. This medication may elevate potassium levels, so blood potassium levels should be monitored regularly when taken with potassium supplements or potassium-rich foods. Patients with impaired kidney function may experience worsened kidney function, necessitating regular kidney function testing. Caution is advised during driving or operating hazardous machinery, as drowsiness or dizziness may lead to accidents. Interactions may occur when taken with other antihypertensive medications or certain drugs, so it's critical to inform healthcare professionals about all medications being taken. In cases of overdose, symptoms like severe hypotension or heart problems may arise, so the prescribed dosage must be strictly followed, and if any abnormal symptoms appear, immediate medical attention is required. This medication is not recommended for children due to insufficient data on safety and efficacy.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects it from light, at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents deterioration.
A white and light blue, bi-convex, oval-shaped tablet.
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Aliko Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.